Suppr超能文献

培养的L5178Y细胞中的特定基因突变。

Specific gene mutations in L5178Y cells in culture.

作者信息

Clive D, McCuen R, Spector J F, Piper C, Mavournin K H

出版信息

Mutat Res. 1983 Jun;115(2):225-51. doi: 10.1016/0165-1110(83)90005-2.

Abstract

The predominant test system uses a near-diploid L5178Y mouse lymphoma cell line and is based on the quantitation of forward mutations occurring at the heterozygous thymidine kinase (TK) locus (TK+/- leads to TK-/-). (Other markers, such as ouabain- or methothrexate-resistance and alanine independence, in other L5178Y mouse lymphoma cells were also examined, but our criteria for the acceptability of data or the paucity of data considerably reduced the value of these mutagenesis test systems to this study.) The biochemical basis for the L5178Y/TK+/- assay depends on the ability of TK-competent cells to phosphorylate 5-bromo-2'-deoxyuridine or trifluorothymidine. The phosphorylated product or its metabolites kill these cells, thus, medium containing 5-bromo-2'-deoxyuridine or trifluorothymidine is capable of selecting for cells that are lacking the TK enzyme (TK-/-). TK-/- cells eventually give rise to a bimodal distribution of colony sizes. The relative proportion of small and large colonies appears to be characteristic of the mutagen, its dose, and the length of the expression period. A total of 108 references were reviewed and 48 chemical agents were evaluated. Of these, in vivo carcinogenicity data existed for 44 and covered a wide variety of chemical classes (43 compounds) and a complex mixture. In this system, 39 agents were positive, 1 was negative, and 4 yielded inconclusive results. The 44 test substances evaluated were insufficient to single out agents or agent classes for which the assay was particularly well suited; however, with the exception of thymidine analogs, the system seems to be versatile. The correlation of the TK locus assay results with the carcinogenicity data revealed that 2 agents were definite false positives (sodium azide and methotrexate) and 1 agent was a definite false negative (1,1-dimethylhydrazine). Further evaluation suggested that 4-acetylaminofluorene and diphenylnitrosamine were questionable false positives, while benzo[e]pyrene was a questionable false negative. (The term questionable was used to imply uncertainties concerning the mutagenicity and/or carcinogenicity data). Thus, the assay is of value in the battery approach to mutagenicity/carcinogenicity screening.

摘要

主要的测试系统使用近二倍体L5178Y小鼠淋巴瘤细胞系,基于对杂合胸苷激酶(TK)位点发生的正向突变进行定量分析(TK+/- 导致TK-/-)。(还检测了其他L5178Y小鼠淋巴瘤细胞中的其他标记,如哇巴因或甲氨蝶呤抗性以及丙氨酸非依赖性,但我们的数据可接受性标准或数据的匮乏大大降低了这些诱变测试系统在本研究中的价值。)L5178Y/TK+/- 检测的生化基础取决于具有TK活性的细胞磷酸化5-溴-2'-脱氧尿苷或三氟胸苷的能力。磷酸化产物或其代谢物会杀死这些细胞,因此,含有5-溴-2'-脱氧尿苷或三氟胸苷的培养基能够筛选出缺乏TK酶(TK-/-)的细胞。TK-/- 细胞最终会产生菌落大小的双峰分布。小菌落和大菌落的相对比例似乎是诱变剂、其剂量和表达期长度的特征。共查阅了108篇参考文献,评估了48种化学试剂。其中,44种有体内致癌性数据,涵盖了多种化学类别(43种化合物)和一种复杂混合物。在该系统中,39种试剂呈阳性,1种呈阴性,4种结果不确定。所评估的44种测试物质不足以挑选出该检测特别适用的试剂或试剂类别;然而,除了胸苷类似物外,该系统似乎具有通用性。TK位点检测结果与致癌性数据的相关性表明,有2种试剂肯定为假阳性(叠氮化钠和甲氨蝶呤),1种试剂肯定为假阴性(1,1-二甲基肼)。进一步评估表明,4-乙酰氨基芴和二苯基亚硝胺是可疑假阳性,而苯并[e]芘是可疑假阴性。(术语“可疑”用于表示关于诱变性和/或致癌性数据的不确定性)。因此,该检测在致突变性/致癌性筛选的组合方法中具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验